000 01390 a2200421 4500
005 20250518030804.0
264 0 _c20200114
008 202001s 0 0 eng d
022 _a1529-8019
024 7 _a10.1111/dth.12875
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHong, Joo R
245 0 0 _aRisk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.
_h[electronic resource]
260 _bDermatologic therapy
_c05 2019
300 _ae12875 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aCreatinine
_xblood
650 0 4 _aCyclosporine
_xadministration & dosage
650 0 4 _aDiabetes Mellitus
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aObesity
_xcomplications
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
700 1 _aLee, Yang W
700 1 _aChoe, Yong B
700 1 _aAhn, Kyu J
773 0 _tDermatologic therapy
_gvol. 32
_gno. 3
_gp. e12875
856 4 0 _uhttps://doi.org/10.1111/dth.12875
_zAvailable from publisher's website
999 _c29489859
_d29489859